Records containing: Lymphoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2015-06-08
A Phase 1 Study of LY2875358 in Japanese Patients With Advanced Malignancies
CLINICAL_TRIALS study record update · 2015-06-08
Clinical Correlates of Immunologic Responses to the Flu Vaccine
CLINICAL_TRIALS study record update · 2015-06-04
A Phase I/II Study of Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain
CLINICAL_TRIALS study record update · 2015-05-29
Perception of Caregiver Burden
CLINICAL_TRIALS study record update · 2015-05-27
Transplantation Of Umbilical Cord Blood From Unrelated Donors In Patients With Haematological Diseases Using A Myeloablative Conditioning Regimen
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2015-04-30
A Phase I Trial Of UCN-01 And Prednisone In Patients With Refractory Solid Tumors And Lymphomas
CLINICAL_TRIALS study record update · 2015-04-30
Active Specific Immunotherapy for Follicular Lymphomas With Liposomes Containing Tumor-Derived Antigen and IL-2
CLINICAL_TRIALS study record update · 2015-04-30
Pediatric Phase I Trial of LMB-2 for Refractory CD25-Positive Leukemias and Lymphomas
CLINICAL_TRIALS study record update · 2015-04-30
A Phase II Trial Of Bryostatin-1 In Combination With Rituximab In Rituximab-Refractory Indolent B-cell Non Hodgkin's Lymphoma And Chronic Lymphocytic Leukemia
CLINICAL_TRIALS study record update · 2015-04-30
A Phase I Study Of Therapy With Mono-dgA-RFB4 In Patients With Relapsed And Refractory CD22+ B-Cell Lymphoma
CLINICAL_TRIALS study record update · 2015-04-29
A Phase I Trial of Oral Perifosine With Different Loading Schedules in Patients With Refractory Neoplasms
CLINICAL_TRIALS study record update · 2015-04-29
Phase I Trial of a Four Hour Infusion of Depsipeptide (NSC630176) Given on Days 1 and 5 of a 21 Day Cycle in Patients With Refractory Neoplasms
CLINICAL_TRIALS study record update · 2015-04-29
Phase I and Pharmacokinetic Study of UCN-01 and Fludarabine in Relapsed or Refractory Low-Grade Lymphoid Malignancies
CLINICAL_TRIALS study record update · 2015-04-29
Phase I Trial and Pharmacokinetic Study of Arsenic Trioxide in Pediatric Patients With Refractory Leukemia or Lymphoma
CLINICAL_TRIALS study record update · 2015-04-29
A Phase I Trial of Daily Bolus Flavopiridol for Five Consecutive Days in Patients With Refractory Neoplasms
CLINICAL_TRIALS study record update · 2015-04-29
A Phase lb Trial of the Combination of Bryostatin-1 and Low Dose Interleukin-2: Evaluation of the Functional and Molecular Status of Human Monocytes as Antigen Presenting Cells
CLINICAL_TRIALS study record update · 2015-04-29
PHASE I STUDY OF ANTI-TAC(Fv)-PE38 (LMB-2), A RECOMBINANT SINGLE-CHAIN IMMUNOTOXIN FOR TREATMENT OF TAC-EXPRESSING MALIGNANCIES
CLINICAL_TRIALS study record update · 2015-04-29
Gene Expression Analysis in Cutaneous T-Cell Lymphoma
CLINICAL_TRIALS study record update · 2015-04-28
Phase I Study of Recombinant BL22 Immunotoxin in Patients With CD22-Positive B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
CLINICAL_TRIALS study record update · 2015-04-15
Unrelated Donor Stem Cell Transplant for Patients With Malignant and Non-Malignant Disorders
CLINICAL_TRIALS study record update · 2015-04-13
Phase II Study of Bortezomib in Combination With Cyclophosphamide and Rituximab for Relapsed/Refractory Mantle Cell Lymphoma
CLINICAL_TRIALS study record update · 2015-04-03
A Phase I Pharmacokinetic Study Of Epothilone B Analogue BMS-247550 (NSC 710428D) In Patients With Advanced Malignancies And Varying Levels Of Liver Dysfunction
CLINICAL_TRIALS study record update · 2015-03-26
Immune Consolidation With Activated T Cells Armed With OKT3 x Rituxan (Anti-CD3 x Anti-CD20) Bispecific Antibody (CD20Bi) After Peripheral Blood Stem Cell Transplant for High Risk CD20+ Non-Hodgkin's Lymphomas
CLINICAL_TRIALS study record update · 2015-03-24
A Phase II Study of Epratuzumab, Rituximab (ER)-CHOP for Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
CLINICAL_TRIALS study record update · 2015-03-12
A Phase I Trial Of Sirolimus In Relapsed/Refractory Leukemia And Non-Hodgkin's Lymphoma